Vycor Medical Inc (VYCO)

Name: Vycor Medical Inc (VYCO) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name VYCOR MEDICAL INC · CIK 0001424768 · OTC · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Vycor Medical Inc reported revenue of $1.86M. Revenue grew 17.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.81M.

Key ratios (year ended 2025-12-31)

83.8%

Gross margin

1.8%

Operating margin

-3.9%

Net margin

17.2%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$1.81M	$1.86M	$1.59M	$1.46M	$1.22M	$1.39M	$1.14M	$1.39M	$1.51M	$1.38M	$1.45M
Cost of Revenue	$300.6K	$302.3K	$166.8K	$144.9K	$140.6K	$134.7K	$132.5K	$134.8K	$169.6K	$227.1K	$184.7K
Gross Profit	$1.51M	$1.56M	$1.42M	$1.32M	$1.08M	$1.26M	$1.01M	$1.26M	$1.34M	$1.16M	$1.27M
R&D Expense	n/a	$10.0K	$15.3K	$22.6K	n/a	$15.2K	$0	$0	n/a	$3.0K	$4.7K
Operating Income	$48.2K	$33.9K	-$9.1K	$40.2K	-$306.5K	-$436.0K	-$727.4K	-$601.4K	-$1.32M	-$1.31M	-$1.59M
Depreciation & Amortization	$58.6K	$59.5K	$59.5K	$57.5K	$58.2K	$66.1K	$56.5K	$59.9K	$166.4K	$275.4K	$257.6K
EBITDA	$106.8K	$93.4K	$50.4K	$97.7K	-$248.3K	-$369.9K	-$670.9K	-$541.5K	-$1.15M	-$1.04M	-$1.33M
Net Income	-$59.9K	-$72.4K	-$107.2K	-$69.7K	-$404.9K	-$435.7K	-$822.5K	-$796.2K	-$1.38M	-$1.48M	-$1.65M
EPS (Diluted)	n/a	-$0.01	-$0.01	-$0.01	-$0.02	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	$813.2K	$830.4K	$998.1K	$992.3K	$860.2K	$935.4K	$986.5K	$1.09M	$1.04M	$1.45M	$1.49M
Total Liabilities	$5.06M	$4.92M	$4.69M	$4.32M	$3.80M	$3.33M	$2.97M	n/a	n/a	n/a	n/a
Shareholders' Equity	-$4.25M	-$4.09M	-$3.69M	-$3.33M	-$2.94M	-$2.40M	-$1.98M	-$1.35M	-$768.8K	$81.4K	-$26.4K
Cash & Equivalents	$158.9K	$87.0K	$105.6K	$57.3K	$37.0K	$90.9K	$46.0K	$60.7K	$86.5K	$206.2K	$56.9K
Operating Cash Flow	$61.4K	-$13.5K	$60.1K	$29.4K	-$217.0K	$21.4K	-$248.8K	-$6.0K	-$260.3K	-$527.4K	-$496.9K
Capital Expenditures	n/a	$5.2K	$5.4K	$9.4K	$2.8K	$38.4K	$62.1K	$52.9K	$63.5K	$183.3K	$57.5K
Free Cash Flow	n/a	-$18.7K	$54.7K	$20.0K	-$219.8K	-$17.0K	-$310.8K	-$58.9K	-$323.8K	-$710.7K	-$554.4K
Shares Outstanding	33.37M	33.37M	33.37M	32.63M	32.53M	30.82M	27.43M	25.29M	23.14M	19.82M	11.34M
Weighted Average Diluted Shares	n/a	33.37M	32.88M	32.60M	31.71M	n/a	n/a	n/a	n/a	n/a	n/a
EPS (Basic)	n/a	-$0.01	-$0.01	-$0.01	-$0.02	-$0.03	n/a	n/a	n/a	n/a	n/a